Evidence brief · Supplement

Andrographis for Upper-respiratory infection severity/duration

Evidence grade B — Meta-analytic

Overall grade
Grade B
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade B — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Upper-respiratory infection severity/durationEvidence grade B

    Meta-analytic

    Moderatemixed

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Studies disagree: Upper-respiratory infection severity/duration (mixed agreement).

The evidence in words

The verdict

For upper-respiratory infection severity/duration, Andrographis earns evidence grade B (moderate effect, mixed consistency) — there is real evidence here. Meta-analytic

How it might work

Anti-inflammatory and immune-modulating actions on respiratory symptoms.

How to use it

Standardized andrographolide at onset and through symptoms.

Safety & cautions

GI upset, allergy; possible additive immune/anticoagulant effects; avoid in pregnancy.

Bottom line

A genuinely useful cold-symptom herb — among the best-supported. Standardized product at onset; avoid in pregnancy.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

Standard
Standardized andrographolide at onset.

Goes with

  • AndrographisRead the full Andrographis monographEvidence grade B

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.